Sirion Portfolio
- 1. Product and Service Portfolio Adenovirus, Cell Pools or clonal cells for -Knock Down and Vectors Ready-to-Use Cells -Virus construction , Overexpression using purification, enhancement AV, AAV or LV technology ‘TransMAX’, ‘LentiMAX’ -Custom vector preparations Cell Immortailzation AV miRNA expression systems Immortalized primary Cells - Virus vectors for target validation Industrial - ImHUVEC and Clinical Viral vectors for basic research and Applications Production cell line optimization Drug development Systems Biology-based rational screening Mission® cells (Sigma Aldrich-SirionBiotech) Immortalization of primary human cells New! Cell products for screening Vaccine development option - Targeted genome modification (BAC technology) - hCMV vaccine candidate - Cellular assay systems with specifically modulated - Adenovirus serotype vectors pathways For further information please send an Email to: frost@sirion-biotech.de or call us under: +49 89 700 961 99 16